These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 35924923)

  • 21. Serial Passaging of the Human Rotavirus CDC-9 Strain in Cell Culture Leads to Attenuation: Characterization from
    Resch TK; Wang Y; Moon S; Jiang B
    J Virol; 2020 Jul; 94(15):. PubMed ID: 32461318
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alternative intermolecular contacts underlie the rotavirus VP5* two- to three-fold rearrangement.
    Yoder JD; Dormitzer PR
    EMBO J; 2006 Apr; 25(7):1559-68. PubMed ID: 16511559
    [TBL] [Abstract][Full Text] [Related]  

  • 23. VP4- and VP7-specific antibodies mediate heterotypic immunity to rotavirus in humans.
    Nair N; Feng N; Blum LK; Sanyal M; Ding S; Jiang B; Sen A; Morton JM; He XS; Robinson WH; Greenberg HB
    Sci Transl Med; 2017 Jun; 9(395):. PubMed ID: 28637924
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Production and characterization of murine IgA monoclonal antibodies to the surface antigens of rhesus rotavirus.
    Giammarioli AM; Mackow ER; Fiore L; Greenberg HB; Ruggeri FM
    Virology; 1996 Nov; 225(1):97-110. PubMed ID: 8918537
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New insights into rotavirus entry machinery: stabilization of rotavirus spike conformation is independent of trypsin cleavage.
    Rodríguez JM; Chichón FJ; Martín-Forero E; González-Camacho F; Carrascosa JL; Castón JR; Luque D
    PLoS Pathog; 2014 May; 10(5):e1004157. PubMed ID: 24873828
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Visualization of Calcium Ion Loss from Rotavirus during Cell Entry.
    Salgado EN; Garcia Rodriguez B; Narayanaswamy N; Krishnan Y; Harrison SC
    J Virol; 2018 Dec; 92(24):. PubMed ID: 30258012
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reverse Genetics Approach for Developing Rotavirus Vaccine Candidates Carrying VP4 and VP7 Genes Cloned from Clinical Isolates of Human Rotavirus.
    Kanai Y; Onishi M; Kawagishi T; Pannacha P; Nurdin JA; Nouda R; Yamasaki M; Lusiany T; Khamrin P; Okitsu S; Hayakawa S; Ebina H; Ushijima H; Kobayashi T
    J Virol; 2020 Dec; 95(2):. PubMed ID: 33087468
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trypsin activation pathway of rotavirus infectivity.
    Arias CF; Romero P; Alvarez V; López S
    J Virol; 1996 Sep; 70(9):5832-9. PubMed ID: 8709201
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Role of the VP4 Attachment Protein in Rotavirus Host Range Restriction in an
    Sánchez-Tacuba L; Kawagishi T; Feng N; Jiang B; Ding S; Greenberg HB
    J Virol; 2022 Aug; 96(15):e0055022. PubMed ID: 35862708
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trypsin cleavage stabilizes the rotavirus VP4 spike.
    Crawford SE; Mukherjee SK; Estes MK; Lawton JA; Shaw AL; Ramig RF; Prasad BV
    J Virol; 2001 Jul; 75(13):6052-61. PubMed ID: 11390607
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assembly of highly infectious rotavirus particles recoated with recombinant outer capsid proteins.
    Trask SD; Dormitzer PR
    J Virol; 2006 Nov; 80(22):11293-304. PubMed ID: 16971442
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A rotavirus spike protein conformational intermediate binds lipid bilayers.
    Trask SD; Kim IS; Harrison SC; Dormitzer PR
    J Virol; 2010 Feb; 84(4):1764-70. PubMed ID: 20007281
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Generation and characterization of mouse monoclonal antibodies against the VP4 protein of group A human rotaviruses.
    Zeng Y; Song F; Luo G; Yang H; Li C; Liu W; Li T; Zhang S; Wang Y; Huang C; Ge S; Zhang J; Xia N
    Antiviral Res; 2022 Nov; 207():105407. PubMed ID: 36152816
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structural Insights into Reovirus σ1 Interactions with Two Neutralizing Antibodies.
    Dietrich MH; Ogden KM; Katen SP; Reiss K; Sutherland DM; Carnahan RH; Goff M; Cooper T; Dermody TS; Stehle T
    J Virol; 2017 Feb; 91(4):. PubMed ID: 27928010
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A 3.0-Angstrom Resolution Cryo-Electron Microscopy Structure and Antigenic Sites of Coxsackievirus A6-Like Particles.
    Chen J; Zhang C; Zhou Y; Zhang X; Shen C; Ye X; Jiang W; Huang Z; Cong Y
    J Virol; 2018 Jan; 92(2):. PubMed ID: 29093091
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distribution of conserved and specific epitopes on the VP8 subunit of rotavirus VP4.
    Larralde G; Gorziglia M
    J Virol; 1992 Dec; 66(12):7438-43. PubMed ID: 1279204
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic diversity of G1P[8] rotavirus VP7 and VP8* antigens in Finland over a 20-year period: No evidence for selection pressure by universal mass vaccination with RotaTeq® vaccine.
    Hemming M; Vesikari T
    Infect Genet Evol; 2013 Oct; 19():51-8. PubMed ID: 23831933
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rotavirus capsid protein VP5* permeabilizes membranes.
    Denisova E; Dowling W; LaMonica R; Shaw R; Scarlata S; Ruggeri F; Mackow ER
    J Virol; 1999 Apr; 73(4):3147-53. PubMed ID: 10074166
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A neutralizing monoclonal antibody to bovine rotavirus VP8 neutralizes rotavirus infection without inhibiting virus attachment to MA-104 cells.
    Lee J; Babiuk LA; Yoo D
    Can J Vet Res; 1998 Jan; 62(1):63-7. PubMed ID: 9442942
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design and testing of a highly conserved human rotavirus VP8* immunogenic peptide with potential for vaccine development.
    Mohanty E; Dehury B; Satapathy AK; Dwibedi B
    J Biotechnol; 2018 Sep; 281():48-60. PubMed ID: 29886031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.